APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Multi-Omics Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Multi-Omics Service Market Analysis and Forecast 2026-2032

Report ID 174194060216 April 2026199 pages

Choose your research edition.

Industry ResearchMulti-Omics Service Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Multi-Omics Service Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Multi-Omics Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multi-Omics Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Multi-Omics Service Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Multi-Omics Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Multi-Omics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Multi-Omics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Multi-Omics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Multi-Omics Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Multi-Omics Service include Metware, Genechem, Aptbiotech, Illumina, BGI, Singleronbio, Majorbio Group, Bioprofile and Dalton Bioanalytics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Multi-Omics Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Multi-Omics Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Multi-Omics Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Multi-Omics Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Multi-Omics Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Multi-Omics Service revenue, projected growth trends, production technology, application and end-user industry.

Multi-Omics Service Segment by Company

Metware

Genechem

Aptbiotech

Illumina

BGI

Singleronbio

Majorbio Group

Bioprofile

Dalton Bioanalytics

Source BioScience

Psomagen

Biogenity

Sapient

Creative Biolabs

X-omics

RayBiotech

Sampled

Multi-Omics Service Segment by Type

Single-Cell Multi-omics

Spatial Multi-omics

Others

Multi-Omics Service Segment by Application

Cancer Research

Rare Disease Diagnostics

Drug Development

Crop Breeding

Microbiome Research

Others

Multi-Omics Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multi-Omics Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multi-Omics Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multi-Omics Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Multi-Omics Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Multi-Omics Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Multi-Omics Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Multi-Omics Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single-Cell Multi-omics Major Player Table 3. Spatial Multi-omics Major Player Table 4. Others Major Player Table 5. Global Multi-Omics Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Cancer Research Major Player Table 7. Rare Disease Diagnostics Major Player Table 8. Drug Development Major Player Table 9. Crop Breeding Major Player Table 10. Microbiome Research Major Player Table 11. Others Major Player Table 12. Multi-Omics Service Industry Trends Table 13. Multi-Omics Service Industry Drivers Table 14. Multi-Omics Service Industry Opportunities and Challenges Table 15. Multi-Omics Service Industry Restraints Table 16. Global Multi-Omics Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Multi-Omics Service Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Multi-Omics Service Market Share by Region (2021-2026) Table 19. Global Multi-Omics Service Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Multi-Omics Service Market Share by Region (2027-2032) Table 21. Global Multi-Omics Service Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Multi-Omics Service Revenue Market Share by Players (2021-2026) Table 23. Global Multi-Omics Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Multi-Omics Service Key Players Headquarters & Area Served Table 25. Global Multi-Omics Service Players, Product Type & Application Table 26. Global Multi-Omics Service Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Multi-Omics Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Multi-Omics Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Multi-Omics Service Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Multi-Omics Service Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Multi-Omics Service Revenue Market Share by Type (2021-2026) Table 33. Global Multi-Omics Service Revenue Market Share by Type (2027-2032) Table 34. Global Multi-Omics Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Multi-Omics Service Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Multi-Omics Service Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Multi-Omics Service Revenue Market Share by Application (2021-2026) Table 38. Global Multi-Omics Service Revenue Market Share by Application (2027-2032) Table 39. Metware Company Information Table 40. Metware Business Overview Table 41. Metware Multi-Omics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Metware Multi-Omics Service Product Portfolio Table 43. Metware Recent Development Table 44. Genechem Company Information Table 45. Genechem Business Overview Table 46. Genechem Multi-Omics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Genechem Multi-Omics Service Product Portfolio Table 48. Genechem Recent Development Table 49. Aptbiotech Company Information Table 50. Aptbiotech Business Overview Table 51. Aptbiotech Multi-Omics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Aptbiotech Multi-Omics Service Product Portfolio Table 53. Aptbiotech Recent Development Table 54. Illumina Company Information Table 55. Illumina Business Overview Table 56. Illumina Multi-Omics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Illumina Multi-Omics Service Product Portfolio Table 58. Illumina Recent Development Table 59. BGI Company Information Table 60. BGI Business Overview Table 61. BGI Multi-Omics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. BGI Multi-Omics Service Product Portfolio Table 63. BGI Recent Development Table 64. Singleronbio Company Information Table 65. Singleronbio Business Overview Table 66. Singleronbio Multi-Omics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Singleronbio Multi-Omics Service Product Portfolio Table 68. Singleronbio Recent Development Table 69. Majorbio Group Company Information Table 70. Majorbio Group Business Overview Table 71. Majorbio Group Multi-Omics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Majorbio Group Multi-Omics Service Product Portfolio Table 73. Majorbio Group Recent Development Table 74. Bioprofile Company Information Table 75. Bioprofile Business Overview Table 76. Bioprofile Multi-Omics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Bioprofile Multi-Omics Service Product Portfolio Table 78. Bioprofile Recent Development Table 79. Dalton Bioanalytics Company Information Table 80. Dalton Bioanalytics Business Overview Table 81. Dalton Bioanalytics Multi-Omics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Dalton Bioanalytics Multi-Omics Service Product Portfolio Table 83. Dalton Bioanalytics Recent Development Table 84. Source BioScience Company Information Table 85. Source BioScience Business Overview Table 86. Source BioScience Multi-Omics Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Source BioScience Multi-Omics Service Product Portfolio Table 88. Source BioScience Recent Development Table 89. Psomagen Company Information Table 90. Psomagen Business Overview Table 91. Psomagen Multi-Omics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Psomagen Multi-Omics Service Product Portfolio Table 93. Psomagen Recent Development Table 94. Biogenity Company Information Table 95. Biogenity Business Overview Table 96. Biogenity Multi-Omics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Biogenity Multi-Omics Service Product Portfolio Table 98. Biogenity Recent Development Table 99. Sapient Company Information Table 100. Sapient Business Overview Table 101. Sapient Multi-Omics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Sapient Multi-Omics Service Product Portfolio Table 103. Sapient Recent Development Table 104. Creative Biolabs Company Information Table 105. Creative Biolabs Business Overview Table 106. Creative Biolabs Multi-Omics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Creative Biolabs Multi-Omics Service Product Portfolio Table 108. Creative Biolabs Recent Development Table 109. X-omics Company Information Table 110. X-omics Business Overview Table 111. X-omics Multi-Omics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. X-omics Multi-Omics Service Product Portfolio Table 113. X-omics Recent Development Table 114. RayBiotech Company Information Table 115. RayBiotech Business Overview Table 116. RayBiotech Multi-Omics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. RayBiotech Multi-Omics Service Product Portfolio Table 118. RayBiotech Recent Development Table 119. Sampled Company Information Table 120. Sampled Business Overview Table 121. Sampled Multi-Omics Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Sampled Multi-Omics Service Product Portfolio Table 123. Sampled Recent Development Table 124. North America Multi-Omics Service Revenue by Type (2021-2026) & (US$ Million) Table 125. North America Multi-Omics Service Revenue by Type (2027-2032) & (US$ Million) Table 126. North America Multi-Omics Service Revenue by Application (2021-2026) & (US$ Million) Table 127. North America Multi-Omics Service Revenue by Application (2027-2032) & (US$ Million) Table 128. North America Multi-Omics Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. North America Multi-Omics Service Revenue by Country (2021-2026) & (US$ Million) Table 130. North America Multi-Omics Service Revenue by Country (US$ Million) & (2027-2032) Table 131. Europe Multi-Omics Service Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe Multi-Omics Service Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe Multi-Omics Service Revenue by Application (2021-2026) & (US$ Million) Table 134. Europe Multi-Omics Service Revenue by Application (2027-2032) & (US$ Million) Table 135. Europe Multi-Omics Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. Europe Multi-Omics Service Revenue by Country (2021-2026) & (US$ Million) Table 137. Europe Multi-Omics Service Revenue by Country (US$ Million) & (2027-2032) Table 138. China Multi-Omics Service Revenue by Type (2021-2026) & (US$ Million) Table 139. China Multi-Omics Service Revenue by Type (2027-2032) & (US$ Million) Table 140. China Multi-Omics Service Revenue by Application (2021-2026) & (US$ Million) Table 141. China Multi-Omics Service Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Multi-Omics Service Revenue by Type (2021-2026) & (US$ Million) Table 143. Asia Multi-Omics Service Revenue by Type (2027-2032) & (US$ Million) Table 144. Asia Multi-Omics Service Revenue by Application (2021-2026) & (US$ Million) Table 145. Asia Multi-Omics Service Revenue by Application (2027-2032) & (US$ Million) Table 146. Asia Multi-Omics Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 147. Asia Multi-Omics Service Revenue by Region (US$ Million) & (2021-2026) Table 148. Asia Multi-Omics Service Revenue by Region (US$ Million) & (2027-2032) Table 149. SAMEA Multi-Omics Service Revenue by Type (2021-2026) & (US$ Million) Table 150. SAMEA Multi-Omics Service Revenue by Type (2027-2032) & (US$ Million) Table 151. SAMEA Multi-Omics Service Revenue by Application (2021-2026) & (US$ Million) Table 152. SAMEA Multi-Omics Service Revenue by Application (2027-2032) & (US$ Million) Table 153. SAMEA Multi-Omics Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. SAMEA Multi-Omics Service Revenue by Country (2021-2026) & (US$ Million) Table 155. SAMEA Multi-Omics Service Revenue by Country (US$ Million) & (2027-2032) Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Multi-Omics Service Image Figure 2. Global Multi-Omics Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Multi-Omics Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single-Cell Multi-omics Image Figure 5. Spatial Multi-omics Image Figure 6. Others Image Figure 7. Global Multi-Omics Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Multi-Omics Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Cancer Research Image Figure 10. Rare Disease Diagnostics Image Figure 11. Drug Development Image Figure 12. Crop Breeding Image Figure 13. Microbiome Research Image Figure 14. Others Image Figure 15. Global Multi-Omics Service Market Size (US$ Million) & (2021-2032) Figure 16. Global Multi-Omics Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Multi-Omics Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Multi-Omics Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Multi-Omics Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Multi-Omics Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Multi-Omics Service Revenue Market Share by Type (2021-2032) Figure 23. Global Multi-Omics Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Multi-Omics Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Multi-Omics Service Revenue Market Share by Application (2021-2032) Figure 26. North America Multi-Omics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Multi-Omics Service Revenue Share by Type (2021-2032) Figure 28. North America Multi-Omics Service Revenue Share by Application (2021-2032) Figure 29. North America Multi-Omics Service Revenue Share by Country (2021-2032) Figure 30. United States Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Multi-Omics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Multi-Omics Service Revenue Share by Type (2021-2032) Figure 35. Europe Multi-Omics Service Revenue Share by Application (2021-2032) Figure 36. Europe Multi-Omics Service Revenue Share by Country (2021-2032) Figure 37. Germany Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Multi-Omics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Multi-Omics Service Revenue Share by Type (2021-2032) Figure 47. China Multi-Omics Service Revenue Share by Application (2021-2032) Figure 48. Asia Multi-Omics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Multi-Omics Service Revenue Share by Type (2021-2032) Figure 50. Asia Multi-Omics Service Revenue Share by Application (2021-2032) Figure 51. Asia Multi-Omics Service Revenue Share by Region (2021-2032) Figure 52. Japan Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Multi-Omics Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Multi-Omics Service Revenue Share by Type (2021-2032) Figure 60. SAMEA Multi-Omics Service Revenue Share by Application (2021-2032) Figure 61. SAMEA Multi-Omics Service Revenue Share by Country (2021-2032) Figure 62. Brazil Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Multi-Omics Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Single-Cell Multi-omics
  • Spatial Multi-omics
  • Others
Applications
  • Cancer Research
  • Rare Disease Diagnostics
  • Drug Development
  • Crop Breeding
  • Microbiome Research
  • Others
Companies covered
  • Metware
  • Genechem
  • Aptbiotech
  • Illumina
  • BGI
  • Singleronbio
  • Majorbio Group
  • Bioprofile
  • Dalton Bioanalytics
  • Source BioScience
  • Psomagen
  • Biogenity
  • Sapient
  • Creative Biolabs
  • X-omics
  • RayBiotech
  • Sampled

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Multi-Omics Service Market by Type
  3. 1.2.1 Global Multi-Omics Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single-Cell Multi-omics
  5. 1.2.3 Spatial Multi-omics
  6. 1.2.4 Others
  7. 1.3 Multi-Omics Service Market by Application
  8. 1.3.1 Global Multi-Omics Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Cancer Research
  10. 1.3.3 Rare Disease Diagnostics
  11. 1.3.4 Drug Development
  12. 1.3.5 Crop Breeding
  13. 1.3.6 Microbiome Research
  14. 1.3.7 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Multi-Omics Service Market Dynamics
  1. 2.1 Multi-Omics Service Industry Trends
  2. 2.2 Multi-Omics Service Industry Drivers
  3. 2.3 Multi-Omics Service Industry Opportunities and Challenges
  4. 2.4 Multi-Omics Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Multi-Omics Service Market Perspective (2021-2032)
  2. 3.2 Global Multi-Omics Service Growth Trends by Region
  3. 3.2.1 Global Multi-Omics Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Multi-Omics Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Multi-Omics Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Multi-Omics Service Revenue by Players
  2. 4.1.1 Global Multi-Omics Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Multi-Omics Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Multi-Omics Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Multi-Omics Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Multi-Omics Service Key Players Headquarters & Area Served
  7. 4.4 Global Multi-Omics Service Players, Product Type & Application
  8. 4.5 Global Multi-Omics Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Multi-Omics Service Market CR5 and HHI
  11. 4.6.3 2025 Multi-Omics Service Tier 1, Tier 2, and Tier 3
5 Multi-Omics Service Market Size by Type
  1. 5.1 Global Multi-Omics Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Multi-Omics Service Revenue by Type (2021-2032)
  3. 5.3 Global Multi-Omics Service Revenue Market Share by Type (2021-2032)
6 Multi-Omics Service Market Size by Application
  1. 6.1 Global Multi-Omics Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Multi-Omics Service Revenue by Application (2021-2032)
  3. 6.3 Global Multi-Omics Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Metware
  2. 7.1.1 Metware Company Information
  3. 7.1.2 Metware Business Overview
  4. 7.1.3 Metware Multi-Omics Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Metware Multi-Omics Service Product Portfolio
  6. 7.1.5 Metware Recent Developments
  7. 7.2 Genechem
  8. 7.2.1 Genechem Company Information
  9. 7.2.2 Genechem Business Overview
  10. 7.2.3 Genechem Multi-Omics Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Genechem Multi-Omics Service Product Portfolio
  12. 7.2.5 Genechem Recent Developments
  13. 7.3 Aptbiotech
  14. 7.3.1 Aptbiotech Company Information
  15. 7.3.2 Aptbiotech Business Overview
  16. 7.3.3 Aptbiotech Multi-Omics Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Aptbiotech Multi-Omics Service Product Portfolio
  18. 7.3.5 Aptbiotech Recent Developments
  19. 7.4 Illumina
  20. 7.4.1 Illumina Company Information
  21. 7.4.2 Illumina Business Overview
  22. 7.4.3 Illumina Multi-Omics Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Illumina Multi-Omics Service Product Portfolio
  24. 7.4.5 Illumina Recent Developments
  25. 7.5 BGI
  26. 7.5.1 BGI Company Information
  27. 7.5.2 BGI Business Overview
  28. 7.5.3 BGI Multi-Omics Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 BGI Multi-Omics Service Product Portfolio
  30. 7.5.5 BGI Recent Developments
  31. 7.6 Singleronbio
  32. 7.6.1 Singleronbio Company Information
  33. 7.6.2 Singleronbio Business Overview
  34. 7.6.3 Singleronbio Multi-Omics Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Singleronbio Multi-Omics Service Product Portfolio
  36. 7.6.5 Singleronbio Recent Developments
  37. 7.7 Majorbio Group
  38. 7.7.1 Majorbio Group Company Information
  39. 7.7.2 Majorbio Group Business Overview
  40. 7.7.3 Majorbio Group Multi-Omics Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Majorbio Group Multi-Omics Service Product Portfolio
  42. 7.7.5 Majorbio Group Recent Developments
  43. 7.8 Bioprofile
  44. 7.8.1 Bioprofile Company Information
  45. 7.8.2 Bioprofile Business Overview
  46. 7.8.3 Bioprofile Multi-Omics Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Bioprofile Multi-Omics Service Product Portfolio
  48. 7.8.5 Bioprofile Recent Developments
  49. 7.9 Dalton Bioanalytics
  50. 7.9.1 Dalton Bioanalytics Company Information
  51. 7.9.2 Dalton Bioanalytics Business Overview
  52. 7.9.3 Dalton Bioanalytics Multi-Omics Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Dalton Bioanalytics Multi-Omics Service Product Portfolio
  54. 7.9.5 Dalton Bioanalytics Recent Developments
  55. 7.10 Source BioScience
  56. 7.10.1 Source BioScience Company Information
  57. 7.10.2 Source BioScience Business Overview
  58. 7.10.3 Source BioScience Multi-Omics Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Source BioScience Multi-Omics Service Product Portfolio
  60. 7.10.5 Source BioScience Recent Developments
  61. 7.11 Psomagen
  62. 7.11.1 Psomagen Company Information
  63. 7.11.2 Psomagen Business Overview
  64. 7.11.3 Psomagen Multi-Omics Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Psomagen Multi-Omics Service Product Portfolio
  66. 7.11.5 Psomagen Recent Developments
  67. 7.12 Biogenity
  68. 7.12.1 Biogenity Company Information
  69. 7.12.2 Biogenity Business Overview
  70. 7.12.3 Biogenity Multi-Omics Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Biogenity Multi-Omics Service Product Portfolio
  72. 7.12.5 Biogenity Recent Developments
  73. 7.13 Sapient
  74. 7.13.1 Sapient Company Information
  75. 7.13.2 Sapient Business Overview
  76. 7.13.3 Sapient Multi-Omics Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Sapient Multi-Omics Service Product Portfolio
  78. 7.13.5 Sapient Recent Developments
  79. 7.14 Creative Biolabs
  80. 7.14.1 Creative Biolabs Company Information
  81. 7.14.2 Creative Biolabs Business Overview
  82. 7.14.3 Creative Biolabs Multi-Omics Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Creative Biolabs Multi-Omics Service Product Portfolio
  84. 7.14.5 Creative Biolabs Recent Developments
  85. 7.15 X-omics
  86. 7.15.1 X-omics Company Information
  87. 7.15.2 X-omics Business Overview
  88. 7.15.3 X-omics Multi-Omics Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 X-omics Multi-Omics Service Product Portfolio
  90. 7.15.5 X-omics Recent Developments
  91. 7.16 RayBiotech
  92. 7.16.1 RayBiotech Company Information
  93. 7.16.2 RayBiotech Business Overview
  94. 7.16.3 RayBiotech Multi-Omics Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 RayBiotech Multi-Omics Service Product Portfolio
  96. 7.16.5 RayBiotech Recent Developments
  97. 7.17 Sampled
  98. 7.17.1 Sampled Company Information
  99. 7.17.2 Sampled Business Overview
  100. 7.17.3 Sampled Multi-Omics Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Sampled Multi-Omics Service Product Portfolio
  102. 7.17.5 Sampled Recent Developments
8 North America
  1. 8.1 North America Multi-Omics Service Revenue (2021-2032)
  2. 8.2 North America Multi-Omics Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Multi-Omics Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Multi-Omics Service Revenue by Type (2027-2032)
  5. 8.3 North America Multi-Omics Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Multi-Omics Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Multi-Omics Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Multi-Omics Service Revenue by Application (2027-2032)
  9. 8.5 North America Multi-Omics Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Multi-Omics Service Revenue by Country
  11. 8.6.1 North America Multi-Omics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Multi-Omics Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Multi-Omics Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Multi-Omics Service Revenue (2021-2032)
  2. 9.2 Europe Multi-Omics Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Multi-Omics Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Multi-Omics Service Revenue by Type (2027-2032)
  5. 9.3 Europe Multi-Omics Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Multi-Omics Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Multi-Omics Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Multi-Omics Service Revenue by Application (2027-2032)
  9. 9.5 Europe Multi-Omics Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Multi-Omics Service Revenue by Country
  11. 9.6.1 Europe Multi-Omics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Multi-Omics Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Multi-Omics Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Multi-Omics Service Revenue (2021-2032)
  2. 10.2 China Multi-Omics Service Revenue by Type (2021-2032)
  3. 10.2.1 China Multi-Omics Service Revenue by Type (2021-2026)
  4. 10.2.2 China Multi-Omics Service Revenue by Type (2027-2032)
  5. 10.3 China Multi-Omics Service Revenue Share by Type (2021-2032)
  6. 10.4 China Multi-Omics Service Revenue by Application (2021-2032)
  7. 10.4.1 China Multi-Omics Service Revenue by Application (2021-2026)
  8. 10.4.2 China Multi-Omics Service Revenue by Application (2027-2032)
  9. 10.5 China Multi-Omics Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Multi-Omics Service Revenue (2021-2032)
  2. 11.2 Asia Multi-Omics Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Multi-Omics Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Multi-Omics Service Revenue by Type (2027-2032)
  5. 11.3 Asia Multi-Omics Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Multi-Omics Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Multi-Omics Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Multi-Omics Service Revenue by Application (2027-2032)
  9. 11.5 Asia Multi-Omics Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Multi-Omics Service Revenue by Country
  11. 11.6.1 Asia Multi-Omics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Multi-Omics Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Multi-Omics Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Multi-Omics Service Revenue (2021-2032)
  2. 12.2 SAMEA Multi-Omics Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Multi-Omics Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Multi-Omics Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Multi-Omics Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Multi-Omics Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Multi-Omics Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Multi-Omics Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Multi-Omics Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Multi-Omics Service Revenue by Country
  11. 12.6.1 SAMEA Multi-Omics Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Multi-Omics Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Multi-Omics Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst